Dr. Douglas Ward, M.D

NPI: 1396830725
Total Payments
$317,425
2023 Payments
$17.99
Companies
19
Transactions
605
Medicare Patients
128
Medicare Billing
$9,617

Payment Breakdown by Category

Other$188,565 (59.4%)
Consulting$74,790 (23.6%)
Travel$40,572 (12.8%)
Food & Beverage$13,256 (4.2%)
Education$242.14 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $179,065 90 56.4%
Consulting Fee $74,790 25 23.6%
Travel and Lodging $40,572 143 12.8%
Food and Beverage $13,256 338 4.2%
Honoraria $9,500 4 3.0%
Education $242.14 5 0.1%

Top Paying Companies

Company Total Records Latest Year
ViiV Healthcare Company $206,486 305 $0 (2022)
Gilead Sciences, Inc. $51,894 120 $0 (2022)
Merck Sharp & Dohme LLC $39,427 72 $0 (2022)
Theratechnologies Inc. $9,514 17 $0 (2020)
Napo Pharmaceuticals Inc $7,720 11 $0 (2022)
GlaxoSmithKline, LLC. $1,033 10 $0 (2019)
Janssen Biotech, Inc. $649.36 36 $0 (2020)
Janssen Products, LP $228.94 3 $0 (2019)
PFIZER INC. $155.92 11 $0 (2019)
Takeda Pharmaceuticals U.S.A., Inc. $110.16 8 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2023 $17.99 1 MAYNE PHARMA COMMERCIAL LLC ($17.99)
2022 $22,313 18 ViiV Healthcare Company ($16,778)
2021 $21,570 17 ViiV Healthcare Company ($18,410)
2020 $44,259 36 ViiV Healthcare Company ($36,938)
2019 $144,912 262 ViiV Healthcare Company ($100,180)
2018 $47,949 163 ViiV Healthcare Company ($25,100)
2017 $36,404 108 Gilead Sciences Inc ($14,096)

All Payment Transactions

605 individual payment records from CMS Open Payments — Page 1 of 25

Date Company Product Nature Form Amount Type
05/11/2023 MAYNE PHARMA COMMERCIAL LLC Food and Beverage In-kind items and services $17.99 General
10/28/2022 ViiV Healthcare Company DOVATO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,300.00 General
Category: HIV
10/05/2022 ViiV Healthcare Company RUKOBIA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,150.00 General
Category: HIV
08/26/2022 ViiV Healthcare Company Travel and Lodging In-kind items and services $83.13 General
08/26/2022 ViiV Healthcare Company Food and Beverage In-kind items and services $80.20 General
08/26/2022 ViiV Healthcare Company Food and Beverage In-kind items and services $58.08 General
08/26/2022 ViiV Healthcare Company Food and Beverage In-kind items and services $39.82 General
08/26/2022 ViiV Healthcare Company Food and Beverage In-kind items and services $38.72 General
08/26/2022 ViiV Healthcare Company Food and Beverage In-kind items and services $35.95 General
08/25/2022 ViiV Healthcare Company Travel and Lodging In-kind items and services $324.05 General
08/25/2022 ViiV Healthcare Company Travel and Lodging In-kind items and services $269.25 General
08/18/2022 ViiV Healthcare Company Travel and Lodging In-kind items and services $327.95 General
04/15/2022 Napo Pharmaceuticals Inc Mytesi (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $930.00 General
Category: Infectious Disease
04/11/2022 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $1,860.00 General
03/03/2022 ViiV Healthcare Company Consulting Fee Cash or cash equivalent $2,070.00 General
03/02/2022 ViiV Healthcare Company Consulting Fee Cash or cash equivalent $2,240.42 General
01/14/2022 Napo Pharmaceuticals Inc Mytesi (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,325.00 General
Category: Infectious Disease
01/13/2022 Gilead Sciences, Inc. Biktarvy (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $420.00 General
Category: HIV
01/04/2022 ViiV Healthcare Company RUKOBIA (Drug) Consulting Fee Cash or cash equivalent $2,760.00 General
Category: HIV
11/16/2021 ViiV Healthcare Company RUKOBIA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,800.00 General
Category: HIV
09/15/2021 Gilead Sciences, Inc. Biktarvy (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,660.00 General
Category: HIV
08/17/2021 ViiV Healthcare Company DOVATO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,200.00 General
Category: HIV
08/16/2021 ViiV Healthcare Company DOVATO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,200.00 General
Category: HIV
07/27/2021 ViiV Healthcare Company RUKOBIA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,200.00 General
Category: HIV
06/29/2021 ViiV Healthcare Company RUKOBIA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,200.00 General
Category: HIV

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 2 42 50 $12,140 $4,666
2020 3 86 100 $18,116 $4,951
Total Patients
128
Total Services
150
Medicare Billing
$9,617
Procedure Codes
5

All Medicare Procedures & Services

5 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 16 16 $5,136 $2,485 48.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 26 34 $7,004 $2,181 31.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 18 18 $5,778 $2,454 42.5%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 46 59 $12,154 $2,430 20.0%
36415 Insertion of needle into vein for collection of blood sample Office 2020 22 23 $184.00 $67.74 36.8%

About Dr. Douglas Ward, M.D

Dr. Douglas Ward, M.D is a Internal Medicine healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396830725.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Ward, M.D has received a total of $317,425 in payments from pharmaceutical and medical device companies, with $17.99 received in 2023. These payments were reported across 605 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($179,065).

As a Medicare-enrolled provider, Ward has provided services to 128 Medicare beneficiaries, totaling 150 services with total Medicare billing of $9,617. Data is available for 2 years (2020–2021), covering 5 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Washington, DC
  • Active Since 10/03/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1396830725

Products in Payments

  • DOVATO (Drug) $91,717
  • JULUCA (Drug) $28,376
  • RUKOBIA (Drug) $25,810
  • Biktarvy (Drug) $19,738
  • TROGARZO (Drug) $9,130
  • Genvoya (Drug) $7,853
  • Mytesi (Drug) $7,720
  • DELSTRIGO (Drug) $6,834
  • Descovy (Drug) $6,758
  • TIVICAY (Drug) $5,570
  • PIFELTRO (Drug) $3,703
  • PREZCOBIX (Drug) $482.75
  • TRIUMEQ (Drug) $285.65
  • Symtuza (Drug) $258.28
  • Trintellix (Drug) $110.16
  • Juluca (Drug) $107.28
  • ISENTRESS (Drug) $106.54
  • CHANTIX (Drug) $91.88
  • PREVNAR - 13 (Biological) $45.26
  • Natesto (Drug) $41.34

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Washington